Second Genome logo

Second Genome

ID: 5290739

Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases.

3

Funding Rounds

$67.5m

Money raised

Overview

Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Second Genome has raised a total of $16.5m in funding over 3 rounds.

Key Insights:

  • Second Genome Series A round: $11.5m
  • Second Genome funding round, August 2011: $5m
  • Second Genome Series B round, April 2016: $51m